Larimar Therapeutics Inc. sell Lokrim
Start price
07.01.25
/
20%
€3.92
Target price
07.01.26
-
Performance (%)
-12.76%
Price
12.12.25
€3.40
Summary
This prediction is currently active. The prediction for Larimar Therapeutics Inc. shows a convincing performance of -12.76%. This prediction currently runs until 07.01.26. The prediction end date can be changed by Lokrim at any time. Lokrim has 20% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Larimar Therapeutics Inc. | 8.974% | 8.974% |
| iShares Core DAX® | 0.734% | -0.964% |
| iShares Nasdaq 100 | -2.686% | -2.409% |
| iShares Nikkei 225® | -2.261% | -4.038% |
| iShares S&P 500 | -1.346% | -1.510% |
According to Lokrim what are the pros and cons of Larimar Therapeutics Inc. for the foreseeable future?
Pros
Cons
Below average Marketposition
Probably not worthwhile Investment
Revenue decline/stagnation expected
Comments by Lokrim for this prediction
In the thread Zafgen Inc. diskutieren
Sell Larimar Therapeutics Inc.
Stopped prediction by Lokrim for Larimar Therapeutics Inc.
Larimar Therapeutics Inc.
Start price
Target price
Perf. (%)
€11.40
17.05.21
17.05.21
-
17.05.22
17.05.22
-79.82%
18.05.22
18.05.22
